Procept Biorobotics
PRCT
58 hedge funds and large institutions have $1.03B invested in Procept Biorobotics in 2021 Q3 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
64.41% more ownership
Funds ownership: 0% → 64.41% (+64%)
Top Buyers
| 1 |
CI
CPMG Inc
Dallas,
Texas
|
+$431M |
| 2 |
Viking Global Investors
Stamford,
Connecticut
|
+$188M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$129M |
| 4 |
PA
Perceptive Advisors
New York
|
+$63.6M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$51.5M |
Top Sellers
PRCT Hedge Fund Activity: Q3 2021 in Review
58 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q3 2021, worth a combined $1.03B.
Buyers outnumbered sellers: 58 funds opened new PRCT positions and 0 closed out — a net gain of 58 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was CPMG Inc, opening a new position worth an estimated $431M.
- 58 institutional investors held Procept Biorobotics (PRCT) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $1.03B of Procept Biorobotics stock for Q3 2021.
- 58 funds opened new Procept Biorobotics positions in Q3 2021 and 0 closed out, a net change of +58 holders.
- The largest Procept Biorobotics buyer in Q3 2021 was CPMG Inc, an estimated $431M added.
Based on aggregated 13F filings for Q3 2021.